Looks like you clickedhttp://globenewswire.com/news-release/2015/01/09/696279/10114858/en/Portola-Announces-Phase-3-ANNEXA-R-Study-of-Andexanet-Alfa-and-Factor-Xa-Inhibitor-XARELTO-R-rivaroxaban-Met-Primary-Endpoint-With-High-Statistical-Significance.html#sthash.qRfdT7P2.dpuf
If you do not want to visit that page, you can close this browser tab.
